FiscalNote Provides Further Detail on Anticipated Stablecoin Integration for Global Payments After GENIUS Act Passage
With the GENIUS Act now signed into law, the United States has established a standardized and more transparent framework for digital assets. This legislation brings greater clarity and predictability to the cryptocurrency landscape, creating new opportunities for companies and customers to navigate the market with more confidence as the broader regulatory environment continues to evolve. FiscalNote is closely tracking additional legislative and regulatory developments such as the Clarity Act, a crypto market-structure bill recently passed by the U.S. House of Representatives. To do so, the Company is leveraging the same data and analysis it offers to its customers, including the proprietary, award-winning content from CQ.
In parallel, the Company's PolicyNote platform is growing rapidly, with daily active users now exceeding the legacy FiscalNote platform. PolicyNote's intuitive interface and scalable architecture position it for rapid global adoption. The Company previously announced that in order to reduce friction for international customers, it is exploring stablecoins as an additional payment option. Gerry Campbell, who joined FiscalNote earlier this year as Strategic Advisor for Technology Acceleration, is leading those initial efforts. Campbell brings hands-on expertise as a founder, CTO, and CEO in a number of crypto and blockchain-based initiatives.
The Company is currently evaluating potential platforms and partners for this global acceleration initiative. To reduce barriers and simplify transactions as PolicyNote grows, the Company plans to leverage stablecoins as a new payment option for incoming and existing customers. In particular, doing so would make it easier for international customers to start and expand their relationships with FiscalNote, thereby accelerating new customer acquisition, cross-sell, and upsell opportunities.
'This is a great example of FiscalNote putting our own policy expertise to work — spotting emerging regulatory change and turning it into a practical business opportunity,' said Josh Resnik, CEO & President of FiscalNote. 'As digital asset regulations evolve, we're moving quickly to explore ways to reduce friction for customers, expand internationally, and model the agility we deliver to clients every day.'
For more information about FiscalNote's suite of AI-powered policy and regulatory solutions, visit www.fiscalnote.com.
About FiscalNote
FiscalNote (NYSE: NOTE) is the leading provider of AI-driven policy and regulatory intelligence solutions. By uniquely combining proprietary AI technology, comprehensive data, and decades of trusted analysis, FiscalNote helps customers efficiently manage political and business risk. Since 2013, FiscalNote has pioneered solutions that deliver critical insights, enabling effective decision making and giving organizations the competitive edge they need. Home to PolicyNote, CQ, Roll Call, VoterVoice, and many other industry-leading products and brands, FiscalNote serves thousands of customers worldwide with global offices in North America, Europe, and Asia. To learn more about FiscalNote and its suite of solutions, visit FiscalNote.com and follow @FiscalNote.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
UBS Boosts Uber (UBER) PT to $115 on Strong Q1 Profitability, Growth
Uber Technologies Inc. (NYSE:UBER) is one of the most profitable growth stocks to buy according to billionaires. On July 29, UBS analyst Stephen Ju raised the firm's price target on Uber to $115 from $107 while keeping a Buy rating on the shares. Q1 2025 was a profitable quarter for the company, with trips increasing by 18% year-over-year to 3 billion, which was driven by a 14% growth in Monthly Active Platform Consumers/MAPCs to 170 million. The company's profitability saw an improvement. Income from operations was $1.2 billion, which was up by $1.1 billion from the previous year. Net income attributable to Uber was $1.8 billion, which included a $51 million net benefit from revaluations of equity investments. At the end of the quarter, the company held $6 billion in unrestricted cash, cash equivalents, and short-term investments. A close up view of a hand holding a smartphone, using a ride sharing app. Looking ahead to the second quarter of 2025, Uber provided a positive outlook. The company anticipates Gross Bookings to be between $45.75 and $47.25 billion in Q2, which would represent a constant currency growth of 16-20%. Uber Technologies Inc. (NYSE:UBER) develops and operates proprietary technology applications that operate through 3 segments: Mobility, Delivery, and Freight. While we acknowledge the potential of UBER as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
4 minutes ago
- Yahoo
Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook
Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year. Despite the decline, earnings exceeded both the company's guidance range of 17 cents to 21 cents and the consensus estimate of 20 cents. Revenue came in at $1.24 billion, surpassing the consensus estimate of $1.19 billion and exceeding management's guidance of $1.175 billion to $1.195 billion. Sales grew 5% on a reported basis and 8% on an organic constant currency EBITDA was $238 million in the second quarter of 2025, a 13.5% decrease. Pet Health revenue was $643 million, an increase of 11% on a reported basis, or 10% on an organic constant currency basis. The increase in pet health revenue included a 4% increase in price. New products primarily drove year-over-year volume increases of 6%. The Advantage Family of products and Seresto contributed revenue of $147 million and $113 million, respectively. Farm Animal revenue was $583 million, a decrease of 2% on a reported basis due to the sale of the aqua business, and a 6% increase on an organic constant currency basis. Farm animal organic constant currency revenue growth included a 2% increase from price. Volumes were up 4%, driven by increased volumes in U.S. cattle, led by Experior, and increased volumes in international poultry and swine. The business has seen demand recovery for international swine products, while international poultry demand remains strong. View more earnings on ELAN Sales of the company's international farm animal products benefited from accelerated customer purchases, primarily in China, in advance of expected future tariff increases, estimated to have shifted approximately $10 to $20 million of expected future purchases to the second quarter. Commenting on Elanco's earnings, William Blair said, 'Elanco's second-quarter deck has some positive key product updates for Zenrelia (label update in the U.S.), Quattro (increased sell-through in the second quarter), AdTab (60% growth), and Experior/Bovaer (continued momentum).' Analyst Brandon Vazquez of William Blair said the solid second-quarter update reinforced the belief that Elanco is on track for a multi-year period of improving growth and margins. Full-Year Guidance 'We are raising our 2025 full-year guidance for our strong second quarter execution and more favorable foreign exchange rates, more than offsetting incremental investments to fuel our innovation launches...,' said Bob VanHimbergen, Executive Vice President and CFO of Elanco Animal Health. Elanco anticipates a tailwind to revenue of approximately $35 million from the favorable impact of foreign exchange rates compared with the May earnings call. The company raised fiscal 2025 revenue guidance from $4.51 billion-$4.58 billion to $4.57 billion-$4.62 billion versus the consensus of $4.54 billion. Elanco also increased its 2025 adjusted EPS from 80-86 cents to 85-91 cents versus the consensus of 84 cents. Full year adjusted EBITDA includes a current estimate for net tariff impact of $10 to $14 million versus $16 to $20 million previously. Third-Quarter Guidance Elanco expects a tailwind to revenue of approximately $10 million from the favorable impact of foreign exchange rates compared to the prior year. Excluding the impacts of foreign exchange rates and royalty revenue sold to a third party, the company expects a growth of 4%-6% in organic constant currency revenue. Elanco forecasts third-quarter adjusted earnings of 12-16 cents per share versus the consensus of 13 cents, with sales of $1.08 billion-$1.11 billion compared to the Wall Street estimate of $1.083 billion. The company anticipates growth to be impacted by approximately $15 million in revenue and approximately $10 million in Adjusted EBITDA of pre-tariff customer buying accelerated into the second quarter, primarily in China. Price Action: ELAN stock surged to a 52-week high of $15.79 following the release of stronger-than-expected financial results for the second quarter of 2025. The stock is trading higher by 17.1% to $16.34 at last check Wednesday. Read Next:Photo by T Sxhneider via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
RBC Capital Raises ServiceNow (NOW) PT to $1,200 on Strong Q1, ‘Conservative' Outlook
ServiceNow Inc. (NYSE:NOW) is one of the most profitable growth stocks to buy according to billionaires. On July 24, RBC Capital raised its price target on ServiceNow shares to $1,200 from $1,100, while maintaining an Outperform rating. The firm believes the company's outlook is conservative for Q2 2025, with a solid upside potential. In Q1 2025, ServiceNow reported its biggest-ever first-quarter for net new Annual Contract Value/ACV. The number of Pro Plus deals more than quadrupled year-over-year, and 72 deals were greater than $1 million in net new ACV, which was a rise from 63 a year ago. Additionally, the number of customers generating over $5 million in ACV reached 508. A close-up of a computer engineer working on the code for a cloud connectivity platform. The company generated a subscription revenue of $3.005 billion, which was a 20% year-over-year increase. The company still raised its full-year 2025 subscription revenue guidance to a range of $12.64 billion to $12.68 billion, representing 18.5-19% year-over-year growth. For Q2 alone, subscription revenue guidance was set between $3.030 and $3.035 billion, which is a 19-19.5% growth. ServiceNow Inc. (NYSE:NOW) provides a cloud-based solution for digital workflows in North America, Europe, the Middle East and Africa, Asia Pacific, and internationally. While we acknowledge the potential of NOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
